| 
      Partner's Press
 Release
    
 
 
 
 
 
 
 
 | FOR IMMEDIATE 
      RELEASE: 12/15/2005 The Healthcare Innovation and Convergence Summit Announces Keynote 
      Roster
Healthcare Innovation and Convergence Summit 2006 DARIEN, 
      Conn.--(BUSINESS WIRE)--Dec. 15, 2005--The Healthcare Innovation and 
      Convergence Summit (Health IC) will take place January 23-25, 2006 in New 
      York City.
 The five keynote speakers at the top of the Health IC faculty roster offer 
      diverse and thought-provoking perspectives on key aspects of convergence 
      in healthcare.
 
 -- IBM Healthcare's visionary leader Caroline Kovac will describe the 
      opportunities in life sciences market -- technology, genomic, e-health, 
      pharmaceutical, and agri-science industries.
 
 -- Medtronic's president Bill Hawkins charts the stunning opportunities in 
      medical devices and biomedical engineering.
 
 -- The founder of the Genetics Policy Institute Bernard Siegel will 
      outline the ethical, legal and regulatory issues in stem cell research.
 
 -- Stanford's Walter Bortz presents his insight into the important issues 
      of aging and wellness of the developed world's mature populations.
 
 -- And Cambridge University's Aubrey de Grey extends the discussion by 
      describing science's eventual cure for aging itself, leading to life spans 
      of a thousand years or longer.
 
 The Health IC Summit explores disruptive innovations in healthcare, new 
      developments that change the value proposition in the medical field, often 
      quite dramatically. A three-day, four-track conference program of 
      seminars, panels, and roundtables covers new science, technology and 
      business approaches to stem cells and regenerative medicine, innovative 
      patient care, medical informatics and a finance forum.
 
 Other esteemed conference presenters at Health IC include:
 
 -- Stephen J. Ubl, President & CEO, AdvaMed
 
 -- G. Steven Burrill, Chief Executive Officer, Burrill & Company
 
 -- Stephen Herrara, News Editor, Nature Biotechnology
 
 -- Daniel Callahan, Co-Founder/Director, International Programs, The 
      Hastings Center.
 
 -- Jennifer Elisseeff, PhD, Assistant Professor, Dept.of Biomedical 
      Engineering & Orthopedic Surgery, Johns Hopkins University
 
 -- Alex (Sandy) Pentland, Toshiba Professor of Media Arts & Sciences, MIT 
      Media Lab
 
 -- Jason Pontin, Editor-in-Chief, Technology Review
 
 -- Christopher Scott, Author "Stem Cell Now," Journalist and Executive 
      Director, Stanford Center for Biomedical Ethics Program in Stem Cells and 
      Society
 
 -- Michael Goldberg, General Partner, Mohr, Davidow Ventures
 
 -- Matt Eyring, Managing Director, Innosight
 
 For complete information visit: www.healthicsummit.com
 
 For complimentary press registration visit: http://www.healthicsummit.com/press_reg.asp 
      or contact Laila Hawe at lhawe@divcom.com
 
 Diversified Business Communications, based in Portland, Maine, provides 
      information and market access through trade exhibitions, magazine 
      publishing, and online resources on four continents. Other products in the 
      healthcare portfolio include the Complementary & Natural Healthcare Expo 
      and Primary Care Today. For more information, visit:
      www.divbusiness.com
 
      KEYWORDS: HEALTHCARE, MEDICINE, CONFERENCE, REGENERATIVE MEDICINE,
 CONTACT: IN3.ORG
 |   |